COVID-19 VACCINE: A CHALLENGE FOR TRANSPORT AND LOGISTICS
Covid 19 has put a strain on many economic sectors and the pandemic that has resulted has so far caused over 70 million cases and more than one and a half million deaths worldwide. Not to mention the economic damage that has thrown thousands of businesses and workers to the streets. After the pandemic there will be a world to rebuild, but to reach this goal we need a vaccine which in some countries such as the United Kingdom and the United States of America has already arrived, while for Europe we have to wait for the mid January after the certification bodies have given their ok for the administration.
As far as distribution is concerned, the complex machine has already been set in motion, because the vaccine, whether it is from Pfizer or Moderna, requires complex transport and logistic organization operations, since it needs temperatures below freezing in order not to compromise it. effectiveness. And it is for this reason that various transport companies have prepared suitable means for distribution from one place to another, that is, from the exit from theproduction plant to administration. The problem is not when the vaccine arrives at the airport, but when it has to be transported by land, because trucks with special containers are needed, which at the moment, however, nobody has.
Other vaccine candidates should have fewer transport problems, because they require a lower storage temperature, but in any case the challenge is unprecedented, because about 27 million doses should arrive in Italy in this first phase.
To anticipate a possible method of transport is Lamberet, the leading company in Europe in the sector of fittings for temperature-controlled vans. To date, the company is ready to offer vans with nitrogen and CO2 solutions, reaching temperatures of -30 or -40 C. Going below these temperatures is impossible for the moment, as the isothermal structures of the transport vans on wheels they would not resist, but this does not mean that if the vaccine is present, it cannot be administered, because in any case Lamberet reassures us, saying that it is possible to use standard temperature-controlled vehicles that reach -20C and load independent cryo boxes . Furthermore, this system does not affect the quality of the doses to be administered, nor are there unsustainable impacts from an economic point of view.
Distribution will be a challenge, but we strongly believe that once again human ingenuity will succeed; after all, it was created by creating a vaccine just 11 months after the virus was isolated in the laboratory.
« Guarda tutte le news
